Dr. Sharad Lakhanpal, M.D.
What this data tells you about Dr. Lakhanpal
Dr. Sharad Lakhanpal is an optician in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lakhanpal performed 160,222 Medicare services across 5,070 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lakhanpal received a total of $224,314 from 16 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lakhanpal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 145,600 | $4 | $15 |
| Denosumab injection (Prolia/Xgeva) | 2,700 | $18 | $69 |
| Office visit, established patient (30-39 min) | 1,172 | $94 | $377 |
| Complete blood count (CBC) with differential | 1,151 | $7 | $23 |
| Blood draw (venipuncture) | 1,150 | $8 | $27 |
| Sed rate test (inflammation marker) | 1,145 | $3 | $8 |
| C-reactive protein test (inflammation marker) | 1,142 | $5 | $15 |
| Comprehensive metabolic blood panel | 1,141 | $10 | $32 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 768 | $60 | $217 |
| Automated urinalysis | 590 | $2 | $7 |
| Urinalysis with microscopic exam | 520 | $3 | $10 |
| Measurement of complement (immune system proteins), antigen, | 336 | $12 | $36 |
| Vitamin D level test | 298 | $28 | $88 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 282 | $17 | $54 |
| Uric acid level test | 222 | $4 | $14 |
| Measurement of antibody for rheumatoid arthritis assessment | 209 | $12 | $39 |
| Rheumatoid factor level | 209 | $5 | $17 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 208 | $24 | $76 |
| Cardiolipin antibody (tissue antibody) measurement | 208 | $24 | $76 |
| Screening test for autoimmune disorder | 170 | $12 | $36 |
| Screening test for antibody to noninfectious agent | 168 | $12 | $36 |
| X-ray of hand, minimum of 3 views | 103 | $31 | $111 |
| Hepatitis c antibody measurement | 78 | $13 | $43 |
| New patient office visit, complex (60-74 min) | 78 | $163 | $649 |
| Hepatitis b core antibody measurement | 76 | $11 | $36 |
| Hepatitis b surface antibody measurement | 76 | $10 | $32 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 76 | $10 | $31 |
| Foot X-ray, 3+ views | 54 | $28 | $103 |
| Joint injection, major joint | 40 | $48 | $191 |
| X-ray of both knees while standing | 40 | $33 | $123 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $5 | $24 |
| X-ray of upper spine, 2-3 views | 32 | $33 | $120 |
| X-ray of lower and sacral spine, 2-3 views | 29 | $33 | $120 |
| Shoulder X-ray, 2+ views | 29 | $29 | $104 |
| Ferritin level test (iron stores) | 27 | $13 | $41 |
| Creatine kinase (cardiac enzyme) level, total | 21 | $6 | $19 |
| Office visit, established patient, complex (40-54 min) | 13 | $145 | $506 |
| Flu vaccine administration | 13 | $31 | $80 |
| Flu vaccine, high-dose | 12 | $72 | $587 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lakhanpal is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lakhanpal experienced with certolizumab injection (cimzia)?
Does Dr. Lakhanpal receive payments from pharmaceutical companies?
How do Dr. Lakhanpal's costs compare to other opticians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology